title: HIV seroconversion in the third trimester of pregnancy: using raltegravir to prevent mother-to-child transmission.
abstract: We describe a case of acute HIV infection in the third trimester of pregnancy associated with an extremely high viral load and the use of raltegravir to prevent HIV mother-to-child transmission.
authors: Department of Genitourinary Medicine, St George's University Hospital, Blackshaw Road, London SW17 0QT, UK.
authors: A
authors: A
authors: Hegazi
authors: P
authors: P
authors: Hay
mesh_terms: D000328:Adult; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission; D006679:HIV Seropositivity / Q000188:drug therapy / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019429:Integrase Inhibitors / Q000627:therapeutic use*; D009035:Mothers; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D011760:Pyrrolidinones / Q000627:therapeutic use*; D000068898:Raltegravir Potassium; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019429:Integrase Inhibitors; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium
keywords: AIDS; HIV; PMTCT; antiretroviral therapy; integrase inhibitors; pregnancy; prevention of mother-to-child transmission; raltegravir